Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tampa, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Akari Therapeutics Plc has filed 726 SEC EDGAR filings since 13 Apr 2012

SEC filing history

Showing 301-325 of 726 matching filings.

Per page
25
Current page
13
F-6EF File 333-262049

F-6EF filing

Filing date
07 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-251673

424B5

Filing date
04 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
04 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
21 Dec 2021
Reporting date
21 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
03 Dec 2021
Reporting date
03 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
01 Dec 2021
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
25 Oct 2021
Reporting date
25 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87614

SC 13D/A

Filing date
18 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-239923

EFFECT filing

Filing date
01 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-234219

EFFECT filing

Filing date
01 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-233048

EFFECT filing

Filing date
01 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-227752

EFFECT filing

Filing date
01 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-233048

POS AM

Filing date
30 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-239923

POS AM

Filing date
30 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-234219

POS AM

Filing date
30 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-227752

POS AM

Filing date
30 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-258918

EFFECT filing

Filing date
31 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3/A File 333-258918

F-3/A

Filing date
30 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3 File 333-258918

FORM F-3

Filing date
19 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-407386

D filing

Filing date
22 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
20 Jul 2021
Reporting date
20 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
07 Jul 2021
Reporting date
07 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .